Sign in

NCT05641103Completed

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

Source: ClinicalTrials.gov · Last updated 19 Feb 2026

Brief summary (registry, in English)

The study of splenomegaly, and the follow-up of splenectomized patients, is one of the causes of referral of these patients to pediatric gastroenterology and oncohematology clinics, and adult internal medicine and hematology. It has been described that 0.3% of hospital admissions is for this reason. The study and management of splenomegaly is well described among the different medical specialties to which these patients arrive. After the application of the different algorithms and the different studies that are carried out, these splenomegaly are identified as being of hepatic, infectious, inflammatory, congestive, hematological origin and primary causes. Despite these studies of splenomegaly, approximately 10-15% of these patients still remain undiagnosed. The objective of the present study is to increase the diagnostic sensitivity of these unknown splenomegalys, or unknown splenomegaly patients who remain in consultations, using the usual diagnostic clinical procedures of unknown splenomegaly and unknown splenectomy patients, where the investigators include the extraction of a blood sample for dry drop test (DBS), where the determination of the enzymatic/genetic activity will be carried out for Gaucher disease (GD) and acid sphingomyelinase deficiency (ASMD) , analysis of LisoGl1 and LisoSM.

Status (registry)
Completed
Study type
Observational
Enrollment
122 (actual)
First submitted
29 Nov 2022
Start date
21 Mar 2023
Primary completion date
30 Sept 2024
Lead sponsor
Fundación Española de Hematología y Hemoterapía
NCT number
NCT05641103

What you commit to

  • Study type: Observational
  • Participants enrolled: 122
  • From 21 Mar 2023 to the primary completion date, 30 Sept 2024
  • 14 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Splenomegaly due to portal hypertension (documented by abdominal ultrasound or another instrumental test) caused by liver disease
  • Malignant hematologic tumor \[documented by positive physical examination + blood smear or fine-needle aspiration (FNA) or bone marrow biopsy\]
  • Patients unable to comply with the protocol requirements due to psychiatric and/or cognitive disorders, non-cooperative patients, or educational and written language comprehension limitations

Other

  • Hemolytic anemia and/or thalassemia
  • Patient refusal to participate in the study

Who the study is looking for

  • Adult patients (over 18 years old) of both sexes.
  • Patients presenting signs, assessed instrumentally or via laboratory tests, of:
    • Unexplained splenomegaly, defined as a palpable spleen ≥ 1 cm below the costal margin or diagnosed by ultrasound, magnetic resonance imaging (MRI), or computed tomography (CT) of the spleen.
    • Splenectomized patients without a diagnosis of the cause of unexplained splenomegaly.
  • Patients who provide their consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (14)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Complejo Hospitalario Universitario La Coruña - CHUAC
Coordinator of this site? Confirm its status
A CoruñaSpainUnknown status
Hospital General Universitario de Alicante
Coordinator of this site? Confirm its status
AlicanteSpainUnknown status
Hospital Universitario de Badajoz
Coordinator of this site? Confirm its status
BadajozSpainUnknown status
Hospital Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital de Poniente
Coordinator of this site? Confirm its status
El EjidoSpainUnknown status
Hospital Universitario de Galdácano
Coordinator of this site? Confirm its status
GaldakaoSpainUnknown status
Hospital Universitario de Cabueñes
Coordinator of this site? Confirm its status
GijónSpainUnknown status
Hospital Universitario Juan Ramon Jimenez
Coordinator of this site? Confirm its status
HuelvaSpainUnknown status
Hospital Universitario Lucus Augusti
Coordinator of this site? Confirm its status
LugoSpainUnknown status
Hospital Universitario la Princesa
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Hospital Universitario Central de Asturias (HUCA)
Coordinator of this site? Confirm its status
OviedoSpainUnknown status
CAU Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainUnknown status
Complejo Hospitalario Universitario de Santiago (CHUS)
Coordinator of this site? Confirm its status
Santiago de CompostelaSpainUnknown status
Hospital Universitario Joan XXIII
Coordinator of this site? Confirm its status
TarragonaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.